Business
Bausch Health develops and markets pharmaceuticals, eye-health products and medical devices.
Bausch Health: Revenue grew 6.7% to $10.266B from $9.625B. The company moved from a net loss of $46M to net income of $157M. Free cash flow declined 20.4% to $1.003B from $1.26B. Operating margin expanded 160 bps to 17.66%. Bausch Health's annual comparison also shows free cash flow declined despite revenue growth; stock compensation grew faster than revenue; capital spending grew faster than revenue.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 6.7%OK
- Profitability — The company moved from a net loss of $46M to net income of $157MOK
- Cash flow — Free cash flow declined 20.4% to $1.003B from $1.26BWatch
- Margins — Operating margin expanded 160 bps to 17.66%OK
- Accounting — Distress-range screen needs contextWatch
- Insiders — 5 purchases and 6 salesOK
Where the revenue comes from
Fiscal 2025, as Bausch Health Companies Inc. reports it. History and quarterly detail are in the app.
- Bausch + Lomb$5.1B
- Salix$2.6B
- International$1.1B
- Diversified$937.0M
- Solta Medical$518.0M
Leadership changes
From Bausch Health Companies Inc.'s own filings, the day they're filed.
- Steven D. Miller · directors · departureeff. 2025-08-14
- Brett M. Icahn · directors · departureeff. 2025-08-14
- Michael Goettler · director · appointmenteff. 2025-07-22
Latest filings
- 10-Q · Quarterly report2026-07-30
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-07-01
- 8-K · Company announcement2026-05-19
- 10-Q · Quarterly report2026-04-30
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Bausch Health Companies Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.